Literature DB >> 6412793

Intermittent cyclophosphamide in refractory rheumatoid arthritis.

K Hørslev-Petersen, J M Beyer, P Helin.   

Abstract

Three patients with refractory rheumatoid arthritis were treated with oral cyclophosphamide; in two cases this was supplemented with pulse treatment with methylprednisolone. Long term remission was induced in all three patients and was sustained until follow up at least nine months after the methylprednisolone was stopped. Leucopenia occurred but resolved when cyclophosphamide was reduced from daily to intermittent dosing. Intermittent treatment with cyclophosphamide, possibly in conjunction with pulses of methylprednisolone, may induce remission in patients with rheumatoid arthritis refractory to other forms of treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412793      PMCID: PMC1549032          DOI: 10.1136/bmj.287.6394.711

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  Long-term cyclophosphamide therapy in rheumatoid arthritis.

Authors:  W M Fosdick; J L Parsons; D F Hill
Journal:  Arthritis Rheum       Date:  1968-04

2.  Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis.

Authors:  H J Williams; J C Reading; J R Ward; W M O'Brien
Journal:  Arthritis Rheum       Date:  1980-05

3.  The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens.

Authors:  B L Hazleman
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

  3 in total
  2 in total

1.  Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.

Authors:  Tadashi Nakamura; Yuji Yamamura; Kunihiko Tomoda; Michishi Tsukano; Masahiro Shono; Satoshi Baba
Journal:  Clin Rheumatol       Date:  2003-11-07       Impact factor: 2.980

2.  Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate.

Authors:  M T Walters; M I Cawley
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.